Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
The D2 dopamine receptor (DRD2) is one of the most well-established therapeutic targets for neuropsychiatric and endocrine disorders. Here, the authors report the crystal structure of the antipsychotic drug haloperidol bound to DRD2 via an extended binding pocket that distinguishes it from other D2-...
Enregistré dans:
Auteurs principaux: | Luyu Fan, Liang Tan, Zhangcheng Chen, Jianzhong Qi, Fen Nie, Zhipu Luo, Jianjun Cheng, Sheng Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1936baecc46a4ba180565c58eeea1187 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intoxicación por Haloperidol (Haldol)
par: Filippa,Rolando, et autres
Publié: (1976) -
Discovery of new molecular subtypes in oesophageal adenocarcinoma.
par: Daniela Berg, et autres
Publié: (2011) -
Fluorescent ligands for dopamine D2/D3 receptors
par: Anni Allikalt, et autres
Publié: (2020) -
Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
par: Wesołowska A, et autres
Publié: (2021) -
Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
par: Carine Z. J. Lim, et autres
Publié: (2019)